Company profile for Syntekabio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Syntekabio Inc. is a bioinformatics venture firm founded in 2009. It is a research institute funded by the Korea Electronics and Telecommunications Research Institute (ETRI) '2014 supercomputing technology for genetic testing'. Syntekabio owns Personal Genome Map Technology (PMAP) based on Big data algorithm and it is a genome Big data research institute based on in silico. Syntekabio manages and analyzes genome analysis an...
Syntekabio Inc. is a bioinformatics venture firm founded in 2009. It is a research institute funded by the Korea Electronics and Telecommunications Research Institute (ETRI) '2014 supercomputing technology for genetic testing'. Syntekabio owns Personal Genome Map Technology (PMAP) based on Big data algorithm and it is a genome Big data research institute based on in silico. Syntekabio manages and analyzes genome analysis and massive bio data and genome by with high-performance, high-efficiency supercomputer Syntekabio acquired NET (New Excellent Technology) certified by the government with ‘genetic disease screening technology’.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
South Korea
Address
Address
512, Techno World 2, No. 187, Techno World, Yuseong-Gu, Daejeon-si
Telephone
Telephone
+82-70-7663-0958
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/metavia-announces-ai-driven-collaboration-with-syntekabio-to-explore-additional-indications-for-da-1241-302520330.html

PR NEWSWIRE
04 Aug 2025

https://www.globenewswire.com/news-release/2024/12/20/3000791/0/en/Syntekabio-to-Showcase-AI-Driven-Drug-Discovery-Solutions-at-Biotech-Showcase-2025.html

GLOBENEWSWIRE
20 Dec 2024

https://www.globenewswire.com/news-release/2024/06/20/2901815/0/en/Syntekabio-Signs-Memorandum-of-Understanding-with-bioSeedin-ACROBiosystems.html

GLOBENEWSWIRE
20 Jun 2024

https://www.globenewswire.com/news-release/2024/05/23/2887397/0/en/Syntekabio-to-Showcase-Advanced-AI-Drug-Discovery-Technologies-at-BIO-International-Convention-2024.html

GLOBENEWSWIRE
23 May 2024

https://www.globenewswire.com/news-release/2024/05/07/2876912/0/en/Syntekabio-to-Showcase-Biologics-Discovery-Platform-at-PEGS-Boston.html

GLOBENEWSWIRE
06 May 2024

https://www.globenewswire.com/news-release/2024/04/11/2861630/0/en/Syntekabio-to-Showcase-Innovative-AI-Drug-Discovery-Technologies-at-Bio-IT-World.html

GLOBENEWSWIRE
11 Apr 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty